U108

Sigma-Aldrich

S(−)-UH-301 hydrochloride

solid

Synonym(s):
S(−)-5-Fluoro-8-hydroxy-2-dipropylamino-1,2,3,4-tetrahydronaphthalene hydrochloride, S(−)-5-Fluoro-8-hydroxy-DPAT hydrochloride
Empirical Formula (Hill Notation):
C16H24FNO · HCl
CAS Number:
Molecular Weight:
301.83
MDL number:
PubChem Substance ID:
Pricing and availability is not currently available.

assay

≥98% (HPLC)

form

solid

color

white

solubility

H2O: >20 mg/mL
ethanol: soluble

SMILES string

Cl[H].CCCN(CCC)[C@H]1CCc2c(F)ccc(O)c2C1

InChI

1S/C16H24FNO.ClH/c1-3-9-18(10-4-2)12-5-6-13-14(11-12)16(19)8-7-15(13)17;/h7-8,12,19H,3-6,9-11H2,1-2H3;1H/t12-;/m0./s1

InChI key

FKUVCCNCUAFKAH-YDALLXLXSA-N

Gene Information

human ... HTR1A(3350)

Biochem/physiol Actions

Potent, selective 5-HT1A serotonin receptor antagonist; D2/D3 dopamine receptor agonist.

Caution

hygroscopic, photosensitive

Preparation Note

S(-)-UH-301 hydrochloride is soluble in water (>20 mg/ml) and ethanol.

Personal Protective Equipment

dust mask type N95 (US),Eyeshields,Gloves

RIDADR

NONH for all modes of transport

WGK Germany

3

Certificate of Analysis
Certificate of Origin
S E Hillver et al.
Chirality, 8(8), 531-544 (1996-01-01)
The (S)-enantiomer of 5-fluoro-8-hydroxy-2-(dipropylamino) tetralin [(S)-2a; (S)-UH301] was the first reported 5-HT1A receptor antagonist. We now give a full account on the synthetic effort leading to the preparation of the racemate and the enantiomers of 2a. The crystal and molecular...
L Arborelius et al.
Naunyn-Schmiedeberg's archives of pharmacology, 347(4), 353-362 (1993-04-01)
The effects of the selective 5-HT1A receptor agonist (R)-8-hydroxy-2(di-n-propylamino)tetralin [(R)-8-OH-DPAT] and the novel 5-HT1A antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)-tetralin [(S)-UH-301] were studied with regard to the firing pattern of single mesencephalic dopamine (DA) neurons with extracellular recording techniques in chloral hydrate anesthetized male...
L Björk et al.
European journal of pharmacology, 199(3), 367-370 (1991-07-09)
The 5-HT1A-receptor antagonist (S)-UH-301 (S)-5-fluoro-8-hydroxy-2- (dipropylamino)tetralin) completely antagonized the hypotension and bradycardia induced by (R) = 8-OH DPAT [R)-8-hydroxy-2- (dipropylamino)tetralin) in conscious rats. (S)-UH-301 alone induced a weak hypertension, which might be due to its 5-HT1A-receptor antagonistic properties. (R)-UH-301 induced...
S Ahlenius et al.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 9(1-2), 15-19 (1999-03-19)
The receptor-mediated control of brain monoamine synthesis was used to examine the in vivo intrinsic efficacy of the 5-HT1A receptor antagonists NAD-299, S(-)-UH-301 and WAY-100,635. The rate of monoamine synthesis was estimated by measuring the accumulation of DOPA and 5-HTP...
L Björk et al.
The Journal of pharmacology and experimental therapeutics, 258(1), 58-65 (1991-07-01)
The selective 5-hydroxytryptamine (5-HT1A) receptor agonist 8-hydroxy-2-(dipropylamino)tetralin (8-OH-DPAT) induces a large number of pharmacological effects. In the present study we demonstrate that a novel 8-OH-DPAT analog, (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin [(S)-UH-301], is able to antagonize completely the following (R)-8-OH-DPAT-induced effects in the rat:...

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.